Cadila Healthcare rose 1.21% to Rs 451.75 at 9:46 IST on BSE after the company said it received US drug regulator's final approval for Ethacrynate... ...http://www.business-standard.com/article/news-cm/cadila-healthcare-gains-after-usfda-final-approval-for-drug-117112000172_1.html
Sun Pharmaceutical Industries and Cadila Healthcare second quarter results were the major result announcements this week. ...http://www.moneycontrol.com/news/business/weekly-wrap-pharma-stocks-end-nov-13-17-weekred-as-q2-results-fail-to-spur-investor-interest_10082561.html
Cadila Healthcare Limited, also known as Zydus Cadila, reported a net profit growth of 33 per cent at Rs 503 crore in second quarter ended... ...http://www.business-standard.com/article/companies/cadila-healthcare-s-q2-net-up-33-to-rs-503-cr-117111401320_1.html
To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_11132017.pdf If you would like... ...http://www.sify.com/finance/morning-news-call---india-november-13-news-economy-rlnjueffchbef.html
The Cadila Healthcare stock shed nearly seven per cent in two trading sessions as higher competition for a key drug led brokerages to lower the... ...http://www.business-standard.com/article/markets/competition-clouds-cadila-healthcare-s-fy19-profit-117111200667_1.html
The company was formed way back in...